Creative Biolabs is helping researchers overcome challenges of gene therapy research by providing analytical testing ...
Key market opportunities include the rising prevalence of chronic diseases and increased regulatory approvals driving demand ...
The FDA suspends Regenxbio gene therapy trials for Hurler and Hunter syndromes over safety concerns after a participant ...
Based on Ajinomoto Group’s collaborative development with Forge Biologics, now available worldwide Incheon, Korea — December 2025 — Ajinomoto CELLiST Korea, a subsidiary of the Ajinomoto Group ...
A new study characterizes a bioengineered adeno-associated virus (AAV)3B capsid variant that demonstrates improved transduction to human liver cells. Another advantage of the AAV3B-V04 capsid was its ...
A new study reports the findings of the functional evaluation of six AAV vectors in 12 preclinical models of the human liver. The study, which aimed to uncover which combination of models is the most ...
The "Adeno-Associated Viral (AAV) Vector Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Therapy, Therapeutic Area, Route of Administration, Scale of Operation and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results